Related Experiment Video
Updated: Apr 18, 2026
07:45
An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
Published on: October 21, 2014
8.5K
Consensus statement on preventive and symptomatic care of leukodystrophy patients
Keith Van Haren1, Joshua L Bonkowsky2, Genevieve Bernard3
1Department of Neurology, Lucile Packard Children's Hospital and Stanford University School of Medicine, Stanford, CA, USA.
Molecular Genetics and Metabolism
|January 12, 2015
Summary
Leukodystrophies are rare inherited brain disorders affecting myelin. This expert consensus offers guidance on managing their medical and psychosocial complications, improving patient care.
Area of Science:
- Neurology
- Genetics
- Rare Diseases
Background:
- Leukodystrophies are inherited neurological disorders characterized by myelin dysfunction.
- Despite diverse genetic causes, patients share common symptoms and complications.
- While incurable, leukodystrophies are treatable conditions.
Framework:
- This report establishes the first expert consensus on managing leukodystrophy complications.
- It focuses on recognizing and treating medical and psychosocial issues.
- Preventive care strategies for serious complications are proposed.
Implementation:
- The consensus addresses the recognition and treatment of medical and psychosocial complications.
- It highlights serious, potentially preventable medical issues.
- Preventive care strategies are outlined.
Implications:
- This consensus provides a framework for comprehensive leukodystrophy patient care.
- It emphasizes the need for proactive management of complications.
- Future research is needed to optimize specific care strategies and address clinical priorities.
Related Concept Videos
01:22Lysosomal Hydrolases
4.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.8K
01:24Cystic Fibrosis: Management
656
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
656
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
750
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
750
01:28Chronic Kidney Disease III: Interprofessional Care
662
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
662
01:18Chronic Kidney Disease IV: Nursing Management
669
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
669
01:29Chronic Pancreatitis II: Collaborative Care
538
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
538